Est.1979
Providing Integrated Research Solutions in Preclinical Biology
| Study Title | Reference Drug | End point Parameters |
|---|---|---|
| Anti-psoriatic Potential in Imiquimod (IMQ)-induced skin inflammation in mice | Betamethasone | Cytokine (IL23, IL17, TNF alpha etc..) levels in serum & skin, Clinical score, biopsy weight, histology of skin |
| Anti-psoriatic Potential: TPA induced Skin Inflammation Model in Mice | Betamethasone | Cytokine levels in serum & skin, Clinical score, biopsy weight, histology of skin |
| Atopic Dermatitis Using Oxazolone in BALB/c Mice | Betamethasone, Tacrolimus | Cytokine ( IFN gamma, TNF alpha, IL5, etc..) levels in serum & skin, Clinical score, biopsy weight, histology of skin |
| Antipruritic effect using histamine-induced itching model in mice | Ant-histaminic | No. of scratch , % Activity, serum histamine |
| Wound healing activity using Rat Incision Model | Siver suphadiazine | Growth factor (KGF & VEGF) in skin tissue & skin Histology |
| Wound healing activity using Rat excision Model | Siver suphadiazine | Wound area, Wound contraction, Growth factor (KGF & VEGF) in skin tissue & skin Histology |
| Pressure – wound (Bed sore) model in Rats | Phenytoin | Wound score, Growth factor (VEGF & KGF) in skin tissue & skin Histology |